Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

European Journal of Internal Medicine

Volumn 23, Issue 2, 2012, Pages 169-174

  Montoro García, Silvia ^a   Hernández Romero, Diana ^a   Jover, Eva ^a   García Honrubia, Antonio ^b   Vilchez, Juan A ^a   Casas, Teresa ^a   Martínez, Pedro ^a   Climent, Vicente ^b   Caballero, Luis ^b   Valdés, Mariano ^a   Marín, Francisco ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Biomarker; Clinical features; GDF 15; HCM; Interstitial remodeling

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GADOLINIUM; GELATINASE A; GROWTH DIFFERENTIATION FACTOR 15; TROPONIN T; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE; TREADMILL EXERCISE;

ADULT; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VENTRICULAR REMODELING;

EID: 84856419681     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.08.022     Document Type: Article

References (36)

1. M. de Caestecker The transforming growth factor-beta superfamily of receptors Cytokine Growth Factor Rev 15 2004 1 11 (Pubitemid 38121286)
2. A.R. Bauskin, D.A. Brown, T. Kuffner, H. Johnen, X.W. Luo, and M. Hunter Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer Cancer Res 66 2006 4983 4986 (Pubitemid 43852864)
3. M. Bottner, M. Laaff, B. Schechinger, G. Rappold, K. Unsicker, and C. Suter-Crazzolara Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1) Gene 237 1999 105 111 (Pubitemid 29406202)
4. J. Strelau, A. Schober, A. Sullivan, L. Schilling, and K. Unsicker Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning J Neural Transm Suppl 2003 197 203 (Pubitemid 38339956)
5. M. Albertoni, P.H. Shaw, M. Nozaki, S. Godard, M. Tenan, and M.F. Hamou Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1 Oncogene 21 2002 4212 4219 (Pubitemid 34753827)
6. D. Schlittenhardt, A. Schober, J. Strelau, G.A. Bonaterra, W. Schmiedt, and K. Unsicker Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions Cell Tissue Res 318 2004 325 333 (Pubitemid 39506502)
7. E.C. Hsiao, L.G. Koniaris, T. Zimmers-Koniaris, S.M. Sebald, T.V. Huynh, and S.J. Lee Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury Mol Cell Biol 20 2000 3742 3751 (Pubitemid 30243919)
8. T. Kempf, A. Zarbock, C. Widera, S. Butz, A. Stadtmann, and J. Rossaint GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice Nat Med 17 2011 581 588
9. S.C. de Jager, B. Bermudez, I. Bot, R.R. Koenen, M. Bot, and A. Kavelaars Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis J Exp Med 208 2011 217 225
10. T. Kempf, J.M. Sinning, A. Quint, C. Bickel, C. Sinning, and P.S. Wild Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study Circ Cardiovasc Genet 2 2009 286 292
11. N. Nickel, T. Kempf, H. Tapken, J. Tongers, F. Laenger, and U. Lehmann Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension Am J Respir Crit Care Med 178 2008 534 541
12. K.M. Eggers, T. Kempf, T. Allhoff, B. Lindahl, L. Wallentin, and K.C. Wollert Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain Eur Heart J 29 2008 2327 2335
13. S.Q. Khan, K. Ng, O. Dhillon, D. Kelly, P. Quinn, and I.B. Squire Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction Eur Heart J 30 2009 1057 1065
14. I.S. Anand, T. Kempf, T.S. Rector, H. Tapken, T. Allhoff, and F. Jantzen Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial Circulation 122 2010 1387 1395
15. X. Xu, Z. Li, and W. Gao Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside Biomarkers 16 2011 466 475
16. J. Heger, E. Schiegnitz, D. von Waldthausen, M.M. Anwar, H.M. Piper, and G. Euler Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes J Cell Physiol 224 2010 120 126
17. X. Wang, X. Yang, K. Sun, J. Chen, X. Song, and H. Wang The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension Clin Sci (Lond) 118 2010 137 145
18. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320 (Pubitemid 34250486)
19. V. Roldan, F. Marin, J.R. Gimeno, F. Ruiz-Espejo, J. Gonzalez, and E. Feliu Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy Am Heart J 156 2008 85 91 (Pubitemid 351862294)
20. V. Moreno, D. Hernandez-Romero, J.A. Vilchez, A. Garcia-Honrubia, F. Cambronero, and T. Casas Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy J Card Fail 16 2010 950 956
21. R. O'Hanlon, A. Grasso, M. Roughton, J.C. Moon, S. Clark, and R. Wage Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
22. F. Cambronero, F. Marin, V. Roldan, D. Hernandez-Romero, M. Valdes, and G.Y. Lip Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis Eur Heart J 30 2009 139 151
23. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, and C.E. Seidman American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur Heart J 24 2003 1965 1991 (Pubitemid 37336422)
24. W.J. McKenna, P. Spirito, M. Desnos, O. Dubourg, and M. Komajda Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families Heart 77 1997 130 132 (Pubitemid 27115795)
25. T. Kempf, S. von Haehling, T. Peter, T. Allhoff, M. Cicoira, and W. Doehner Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure J Am Coll Cardiol 50 2007 1054 1060 (Pubitemid 47348231)
26. R. Karam, H.M. Lever, and B.P. Healy Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients J Am Coll Cardiol 13 1989 580 584 (Pubitemid 19073924)
27. P.P. Dimitrow, D. Czarnecka, K. Kawecka-Jaszcz, and J.S. Dubiel The frequency and functional impact of hypertension overlapping on hypertrophic cardiomyopathy: comparison between older and younger patients J Hum Hypertens 12 1998 633 634 (Pubitemid 28458376)
28. L. Monserrat, P.M. Elliott, J.R. Gimeno, S. Sharma, M. Penas-Lado, and W.J. McKenna Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients J Am Coll Cardiol 42 2003 873 879 (Pubitemid 37059747)
29. I. Christiaans, K. van Engelen, I.M. van Langen, E. Birnie, G.J. Bonsel, and P.M. Elliott Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers Europace 12 2010 313 321
30. C.Y. Ho, B. Lopez, O.R. Coelho-Filho, N.K. Lakdawala, A.L. Cirino, and P. Jarolim Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy N Engl J Med 363 2010 552 563
31. G. Kahveci, F. Bayrak, B. Mutlu, and Y. Basaran Determinants of elevated NT-proBNP levels in patients with hypertrophic cardiomyopathy: an echocardiographic study Heart Lung Circ 18 2009 266 270
32. F. Cambronero, J.A. Vilchez, A. Garcia-Honrubia, F. Ruiz-Espejo, V. Moreno, and D. Hernandez-Romero Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy Thromb Res 126 2010 e46 e50
33. J. Xu, T.R. Kimball, J.N. Lorenz, D.A. Brown, A.R. Bauskin, and R. Klevitsky GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation Circ Res 98 2006 342 350
34. L.B. Daniels, P. Clopton, G.A. Laughlin, A.S. Maisel, and E. Barrett-Connor Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study Circulation 123 2011 2101 2110
35. M.P. Bonaca, D.A. Morrow, E. Braunwald, C.P. Cannon, S. Jiang, and S. Breher Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22 Arterioscler Thromb Vasc Biol 31 2011 203 210
36. M.S. Maron, I. Olivotto, A.G. Zenovich, M.S. Link, N.G. Pandian, and J.T. Kuvin Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2006 2232 2239 (Pubitemid 44789498)